摘要:
An aqueous alcoholic fluoroalkyl functional group containing organopolysiloxane- composition, comprising: organopolysiloxanes of formula I: RO�Si(A)(CH.sub.3).sub.z (OR).sub.1-z O!.sub.a �Si(B)(R.sup.2).sub.y (OR).sub.1-y O!.sub.b �Si(C)(CH.sub.3)O!.sub.c �Si(D)(OR)O!.sub.d R.multidot.(HX)(I) wherein A is an aminoalkyl radical derived from the compound of formula II:H.sub.2 N(CH.sub.2).sub.f (NH).sub.g (CH.sub.2).sub.h Si(OR).sub.3-z (CH.sub.3).sub.z (II) wherein 0.ltoreq.f.ltoreq.6, 9=0 if f=0 and g=1 if f>0, 0.ltoreq.h.ltoreq.6 and 0.ltoreq.z.ltoreq.1, and B is a fluoroalkyl radical derived from the compound of formula III: R.sup.1 --Y--(CH.sub.2).sub.2 Si(R.sup.2)y(OR).sub.3-y (III) wherein R.sup.1 is a mono-, oligo- or perfluorinated alkyl group having 1-9 C atoms or a mono-, oligo- or perfluorinated aryl group, Y is a CH.sub.2, O or S group, R.sub.2 is a linear, branched or cyclic alkyl group having 1-8 C atoms or an aryl group and 0.ltoreq.y.ltoreq.1, and C is an alkyl radical derived from the compound of formula IV: R.sup.3 --Si(CH.sub.3)(OR).sub.2 (IV) and D is also an alkyl radical derived from the compound of formula V: R.sup.3 --Si(OR).sub.3 (V) wherein R.sup.3 in the preceding formulae is in each case identical or different, and is a linear, branched or cyclic alkyl group having 1-8 C atoms, R in the preceding formulae is in each case identical or different, and is a linear, branched or cyclic alkyl group having 1-8 C atoms or an aryl group, and HX is an acid, in which X is an inorganic or organic acid radical, and 0.ltoreq.y.ltoreq.1, 0.ltoreq.z.ltoreq.1, a>0, b>0, c>0, d>0, e>0 and (a+b+c+d).gtoreq.2.
摘要翻译:含有有机聚硅氧烷组合物的含水醇的氟代烷基官能团包括:式I的有机聚硅氧烷:RO [Si(A)(CH3)z(OR)1-zO] a [Si(B)(R2)y(OR) yO] b [Si(C)(CH3)O] c [Si(D)(OR)O] dRx(HX)(I)其中A是衍生自式II化合物的氨基烷基:H 2 N(CH 2)f (NH)g(CH 2)h Si(OR)3-z(CH 3)z(II)其中0 0,则g = R =(Y) - (CH 2)2 Si(R 2)y(OR)3-y (III)其中R1是具有1-9个C原子的单,低聚或全氟烷基或单,低聚或全氟化的芳基,Y是CH 2,O或S基团,R 2是直链,支链 或具有1-8个碳原子或芳基且0≤y≤1的环状烷基,C是衍生自式IV化合物的烷基:R3-Si(CH3)(OR)2( IV),D也是衍生自式V化合物的烷基:R 3 -Si(OR)3(V)其中前述通式中的R 3在每种情况下相同 或者不同的是具有1-8个C原子的直链,支链或环状的烷基,前述式中的R各自相同或不同,为具有1-8个C原子的直链,支链或环状的烷基或 芳基,HX是酸,其中X是无机或有机酸基,且0≤z≤1,a> 0,b> 0, c> 0,d> 0,e> 0和(a + b + c + d)> / = 2。
摘要:
An aqueous organopolysiloxane-containing composition comprising organopolysiloxanes of formula I: HO�Si(A) (CH.sub.3).sub.z (OH).sub.1-z O!.sub.a �Si(B) (R.sup.2).sub.y (OH).sub.1-y O!.sub.b �Si(C) (CH.sub.3)O!.sub.c �Si(D) (OH)O!.sub.d H.multidot.(HX).sub.e (I), wherein A is an aminoalkyl group of formula II: H.sub.2 N(CH.sub.2).sub.f (NH).sub.g (CH.sub.2).sub.h Si(OR).sub.3-z (CH.sub.3).sub.z (II), in which 0.ltorsim.f.ltorsim.6, g=0 if f=0 and g=1 if f>0, 0.ltorsim.h.ltorsim.6 and 0.ltorsim.z.ltorsim.1; B is a fluoroalkyl group of formula III: R.sup.1 --Y--(CH.sub.2).sub.2 Si(R.sup.2)y(OR).sub.3-y (III), wherein R.sup.1 is a mono-, oligo- or perfluorinated alkyl group having 1-9 C atoms, or a mono-, oligo- or perfluorinated aryl group, Y is a CH.sub.2, O or S group, R.sup.2 is a linear, branched or cyclic alkyl group having 1-8 C atoms or an aryl group and 0.ltorsim.y.ltorsim.1; C is an alkyl group of formula IV: R.sup.3 --Si(CH.sub.3) (OR).sub.2 (IV), and D is an alkyl group of formula V: R.sup.3 --Si(OR).sub.3 (V), wherein R.sup.3, in each case is identical or different, and is a linear, branched or cyclic alkyl group having 1-8 C atoms, and R, in each case is identical or different, and is a linear, branched or cyclic alkyl group having 1-8 C atoms or an aryl group; and HX is an acid, in which X is an inorganic or organic acid radical, and 0.ltorsim.y.ltorsim.1, 0.ltorsim.z.ltorsim.1, a>0, b>0, c.gtorsim.0, d.gtorsim.0, e.gtorsim.0 and (a+b+c+d).gtorsim.2, the composition being essentially free from organic solvents, having a flash point of more than 70.degree. C. and liberating essentially no alcohols by hydrolysis on dilution with water.
摘要:
The present invention relates to novel heterocyclic compounds of formula I wherein the variables are as defined in the claims or the description, which are useful for inhibiting glycogen synthase kinase 3 (GSK-3), compositions containing the compounds, their use for preparing a medicament for the treatment of a medical disorder susceptible to the treatment with a compound that modulates, preferably inhibits, the activity of glycogen synthase kinase 3β, and methods of treatment of medical disorders susceptible to treatment with a compound that modulates glycogen synthase kinase 3β activity using the compounds.
摘要:
The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity.The carboxamide compounds are compounds of the general formula I in which R1, R2, R3a, R3b, R4, Q, Y, A and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula Ia and Ib in which R1, r, R2b, R3a, R3b, R4, Y and X have the meanings mentioned in the claims, including the tautomers thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein Y is a moiety CH2—CH2, CH2—CH2—CH2, N(Ry#)—CH2, N(Ry#)—CH2—CH2 or CH═CH—CH═, each optionally having 1 or 2 H-atoms replaced with identical or different radicals Ry, wherein Ry and Ry# have the meanings mentioned in the claims.
摘要:
The invention relates to a copolymer which can be used as a superplasticizer for hydraulic binders and comprises 30 to 47 mol % of a (meth)allyl alcohol polyether derivative structural unit and 53 to 70 mol % of a maleic acid derivative structural unit.
摘要:
A process for the preparation of a copolymer in semicontinuous operation in a polymerization apparatus, comprising a polymerization reactor connected to a metering device, acid monomer being initially taken in the metering device and polyether macromonomer, acid monomer and water in the polymerization reactor, acid monomer being metered from the metering device into the polymerization reactor, the metering of the acid monomer being effected with the proviso that at least 70 mol % of the acid monomer metered in altogether are metered in the course of 5 to 19 minutes at a metering rate that is constant or varies to a limited extent.
摘要:
The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity.The carboxamide compounds are compounds of the general formula I in which R1, R2, R3a, R3b, R4, Q, Y, A and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula Ia and Ib in which R1, r, R2b, R3a, R3b, R4, Y and X have the meanings mentioned in the claims, including the tautomers thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein Y is a moiety CH2—CH2, CH2—CH2—CH2, N(Ry#)—CH2, N(Ry#)—CH2—CH2 or CH═CH—CH═, each optionally having 1 or 2 H-atoms replaced with identical or different radicals Ry, wherein Ry and Ry# have the meanings mentioned in the claims.
摘要:
The present invention relates to novel carboxamide compounds and their use for the manufacture of a medicament. The carboxamide compounds are inhibitors of calpain (calcium dependant cysteine proteases). The invention therefore also relates to the use of these carboxamide compounds for treating a disorder associated with an elevated calpain activity.The carboxamide compounds are compounds of the general formula I in which R1, R2, R3a, R3b, R4, Q, Y, A and X have the meanings mentioned in the claims and the description, the tautomers thereof and the pharmaceutically suitable salts thereof. In particular, the compounds have the general formula Ia and Ib in which R1, r, R2b, R3a, R3b, R4, Y and X have the meanings mentioned in the claims, including the tautomers thereof and the pharmaceutically suitable salts thereof. Of these compounds those are preferred wherein Y is a moiety CH2—CH2, CH2—CH2—CH2, N(Ry#)—CH2, N(Ry#)—CH2—CH2 or CH═CH—CH═, each optionally having 1 or 2 H-atoms replaced with identical or different radicals Ry, wherein Ry and Ry# have the meanings mentioned in the claims.
摘要:
The present application relates to calcium channel inhibitors containing compounds of formula (I) wherein Ar1, Ar2, L1, L2, n, R1, R4, X and Y are as defined in the specification. The present application also relates to compositions comprising such compounds, and methods of treating conditions and disorders using such compounds and compositions.
摘要:
The invention relates to a copolymer which is suitable as a superplasticizer for hydraulic binders and comprises 5 to 55 mol % of an isoprenol polyether derivative structural unit, 2 to 90 mol % of an acrylic acid derivative structural unit and 2 to 90 mol % of a hydroxyalkyl acrylate structural unit.